このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Syneos Health, Inc. 競合他社
価格と性能
| Historical stock prices | |
|---|---|
| Current Share Price | US$42.98 |
| 52 Week High | US$52.23 |
| 52 Week Low | US$22.89 |
| Beta | 1.58 |
| 1 Month Change | 0.66% |
| 3 Month Change | 1.99% |
| 1 Year Change | -8.84% |
| 3 Year Change | -23.06% |
| 5 Year Change | -10.61% |
| Change since IPO | 109.76% |
最新ニュース
Recent updates
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 29
Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?
Mar 10Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?
Feb 20Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?
Dec 20Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?
Nov 28Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors
Nov 01Syneos, Datavant expand partnership on data analytics for clinical trials
Oct 11Syneos Health falls 13% after update on outlook
Sep 13When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?
Sep 08Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Aug 22Syneos Health Q2 2022 Earnings Preview
Aug 01With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case
Jul 19Syneos: Upside Could Be Priced In, Valuations Unsupportive
Jul 15Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?
Jun 18Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Jun 03We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt
May 19Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?
Apr 08Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors
Mar 27Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 05Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Feb 18Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?
Feb 03With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting
Jan 04Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022
Dec 03Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Dec 03株主還元
| SYNH | US Life Sciences | US 市場 | |
|---|---|---|---|
| 7D | 0.6% | -2.6% | 1.6% |
| 1Y | -8.8% | -1.0% | 21.5% |
業界別リターン: SYNH過去 1 年間で3.5 % の収益を上げたUS Life Sciences業界を上回りました。
リターン対市場: SYNHは、過去 1 年間で21.8 % のリターンを上げたUS市場を下回りました。
価格変動
| SYNH volatility | |
|---|---|
| SYNH Average Weekly Movement | 0.3% |
| Life Sciences Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
安定した株価: SYNH過去 3 か月間に大きな価格変動はありませんでした。
時間の経過による変動: SYNHの 週次ボラティリティ は、過去 1 年間で9%から0%に減少しました。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2010 | 28,768 | Michelle Keefe | www.syneoshealth.com |
Syneos Health, Inc. 基礎のまとめ
| SYNH 基礎統計学 | |
|---|---|
| 時価総額 | US$4.46b |
| 収益（TTM） | US$71.22m |
| 売上高(TTM) | US$5.42b |
62.6x
PER（株価収益率0.8x
P/SレシオSYNH は割高か？
公正価値と評価分析を参照収益と収入
| SYNH 損益計算書（TTM） | |
|---|---|
| 収益 | US$5.42b |
| 売上原価 | US$4.22b |
| 売上総利益 | US$1.20b |
| その他の費用 | US$1.13b |
| 収益 | US$71.22m |
直近の収益報告
Jun 30, 2023
次回決算日
該当なし
| 一株当たり利益（EPS） | 0.69 |
| グロス・マージン | 22.14% |
| 純利益率 | 1.31% |
| 有利子負債／自己資本比率 | 75.8% |
SYNH の長期的なパフォーマンスは？
過去の実績と比較を見る